Classification, management, and tracking of abnormal Papanicolaou smears.
A system of classifying, managing, and tracking abnormal Papanicolaou (Pap) smears was used at a California university where 3,289 patients were tested. Classification was based on use of the latest cytopathological techniques for identifying characteristics associated with dysplasia and human papilloma virus (HPV). The follow-up success rate was determined for 6-month repeat Pap smears, colposcopy patient contact, and biopsy results. Pathology report correlations were determined for the noncolposcopy group by using repeat Pap smear results. Biopsy results were correlated with Pap smear readings for accuracy and yielded significant statistical information for the program.
Estrin
H M
HM
D002140:California; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D065006:Papanicolaou Test; D013333:Student Health Services; D002578:Uterine Cervical Dysplasia / Q000145:classification / Q000175:diagnosis*; D002583:Uterine Cervical Neoplasms / Q000145:classification / Q000175:diagnosis*; D014626:Vaginal Smears